Cargando…

Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expression

Detalles Bibliográficos
Autores principales: Oki, Y, Buglio, D, Zhang, J, Ying, Y, Zhou, S, Sureda, A, Ben-Yehuda, D, Zinzani, P L, Prince, H M, Harrison, S J, Kirschbaum, M, Johnston, P B, Shen, A, von Tresckow, B, Younes, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219471/
https://www.ncbi.nlm.nih.gov/pubmed/25105535
http://dx.doi.org/10.1038/bcj.2014.58
_version_ 1782342590069211136
author Oki, Y
Buglio, D
Zhang, J
Ying, Y
Zhou, S
Sureda, A
Ben-Yehuda, D
Zinzani, P L
Prince, H M
Harrison, S J
Kirschbaum, M
Johnston, P B
Shen, A
von Tresckow, B
Younes, A
author_facet Oki, Y
Buglio, D
Zhang, J
Ying, Y
Zhou, S
Sureda, A
Ben-Yehuda, D
Zinzani, P L
Prince, H M
Harrison, S J
Kirschbaum, M
Johnston, P B
Shen, A
von Tresckow, B
Younes, A
author_sort Oki, Y
collection PubMed
description
format Online
Article
Text
id pubmed-4219471
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-42194712014-11-04 Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expression Oki, Y Buglio, D Zhang, J Ying, Y Zhou, S Sureda, A Ben-Yehuda, D Zinzani, P L Prince, H M Harrison, S J Kirschbaum, M Johnston, P B Shen, A von Tresckow, B Younes, A Blood Cancer J Letter to the Editor Nature Publishing Group 2014-08 2014-08-08 /pmc/articles/PMC4219471/ /pubmed/25105535 http://dx.doi.org/10.1038/bcj.2014.58 Text en Copyright © 2014 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Letter to the Editor
Oki, Y
Buglio, D
Zhang, J
Ying, Y
Zhou, S
Sureda, A
Ben-Yehuda, D
Zinzani, P L
Prince, H M
Harrison, S J
Kirschbaum, M
Johnston, P B
Shen, A
von Tresckow, B
Younes, A
Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expression
title Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expression
title_full Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expression
title_fullStr Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expression
title_full_unstemmed Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expression
title_short Immune regulatory effects of panobinostat in patients with Hodgkin lymphoma through modulation of serum cytokine levels and T-cell PD1 expression
title_sort immune regulatory effects of panobinostat in patients with hodgkin lymphoma through modulation of serum cytokine levels and t-cell pd1 expression
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219471/
https://www.ncbi.nlm.nih.gov/pubmed/25105535
http://dx.doi.org/10.1038/bcj.2014.58
work_keys_str_mv AT okiy immuneregulatoryeffectsofpanobinostatinpatientswithhodgkinlymphomathroughmodulationofserumcytokinelevelsandtcellpd1expression
AT bugliod immuneregulatoryeffectsofpanobinostatinpatientswithhodgkinlymphomathroughmodulationofserumcytokinelevelsandtcellpd1expression
AT zhangj immuneregulatoryeffectsofpanobinostatinpatientswithhodgkinlymphomathroughmodulationofserumcytokinelevelsandtcellpd1expression
AT yingy immuneregulatoryeffectsofpanobinostatinpatientswithhodgkinlymphomathroughmodulationofserumcytokinelevelsandtcellpd1expression
AT zhous immuneregulatoryeffectsofpanobinostatinpatientswithhodgkinlymphomathroughmodulationofserumcytokinelevelsandtcellpd1expression
AT suredaa immuneregulatoryeffectsofpanobinostatinpatientswithhodgkinlymphomathroughmodulationofserumcytokinelevelsandtcellpd1expression
AT benyehudad immuneregulatoryeffectsofpanobinostatinpatientswithhodgkinlymphomathroughmodulationofserumcytokinelevelsandtcellpd1expression
AT zinzanipl immuneregulatoryeffectsofpanobinostatinpatientswithhodgkinlymphomathroughmodulationofserumcytokinelevelsandtcellpd1expression
AT princehm immuneregulatoryeffectsofpanobinostatinpatientswithhodgkinlymphomathroughmodulationofserumcytokinelevelsandtcellpd1expression
AT harrisonsj immuneregulatoryeffectsofpanobinostatinpatientswithhodgkinlymphomathroughmodulationofserumcytokinelevelsandtcellpd1expression
AT kirschbaumm immuneregulatoryeffectsofpanobinostatinpatientswithhodgkinlymphomathroughmodulationofserumcytokinelevelsandtcellpd1expression
AT johnstonpb immuneregulatoryeffectsofpanobinostatinpatientswithhodgkinlymphomathroughmodulationofserumcytokinelevelsandtcellpd1expression
AT shena immuneregulatoryeffectsofpanobinostatinpatientswithhodgkinlymphomathroughmodulationofserumcytokinelevelsandtcellpd1expression
AT vontresckowb immuneregulatoryeffectsofpanobinostatinpatientswithhodgkinlymphomathroughmodulationofserumcytokinelevelsandtcellpd1expression
AT younesa immuneregulatoryeffectsofpanobinostatinpatientswithhodgkinlymphomathroughmodulationofserumcytokinelevelsandtcellpd1expression